Sclerotherapy comparable to conventional curettage and bone grafting for aneurysmal bone cyst

Written By :  Dr. Nandita Mohan
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-06-10 03:30 GMT   |   Update On 2021-06-10 03:30 GMT
Advertisement

Researchers from a recent study have found out that percutaneous sclerotherapy using polidocanol is a highly effective, cost efficient and safe treatment option with good cosmesis and reduced morbidity when compared to the conventional curettage and bone grafting procedure.

The study is published in the Journal of Orthopaedics.

The standard treatment of Aneurysmal bone cyst is curettage and grafting and is associated with high morbidity. Hence minimal invasive alternative treatment methods such as sclerotherapy are gaining much popularity. Though sclerotherapy has been attributed to reasonable cure rates, undetermined tissue diagnosis often impedes with initiation of treatment.

Advertisement

Therefore, Dominic Puthoor and associates from the Orthopaedic Oncologist, Professor and Head, Dept. of Orthopaedics, Amala Institute of Medical Sciences, India carried out this research to examine if sclerotherapy with polidocanol based on clinic-radiological picture is comparable with the standard intralesional curettage and bone grafting. Attempting biopsy and treatment simultaneously based on the clinico-radiological presentation makes this study unique.

The authors divided 48 patients into two treatment groups. Group 1 treated with percutaneous sclerotherapy using polidocanol and group 2 those treated with extended curettage and bone grafting.

Time to healing and recurrence, pain relief, and radiological outcome using modified Neer's criteria for the radiological healing of the bone cysts were assessed. 31 patients from Group 1 and 17 from Group 2 were available for study. The minimum follow-up was 2 years.

The key findings highlighted were-

  1. At last follow-up, 100% in Group 1 and 82% in Group 2 had achieved complete healing and there was no statistical difference in outcome at 24 months (p = 0.255).
  2. Complications in Group 1 were injection site necrosis, pain and hypopigmentation, all of which resolved spontaneously.
  3. In Group 2, three patients had recurrence.
  4. Despite similar healing rates, we found higher incidence of clinically pertinent complications, poor functional outcomes and increased cost of treatment associated with intralesional excision.
  5. Three cases were excluded from sclerotherapy group as the final diagnosis turned up to be secondary ABC.

Hence, it was concluded that "percutaneous sclerotherapy using polidocanol is a highly effective, cost efficient and safe treatment option with good cosmesis and reduced morbidity. In this study, we found comparable outcomes for both treatment methods however this will require confirmation in larger studies."


Tags:    
Article Source : Journal of Orthopaedics

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News